Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124216343 | 12421634 | 3 | F | 20160502 | 20160627 | 20160531 | 20160704 | EXP | US-PFIZER INC-2016276855 | PFIZER | 46.00 | YR | F | Y | 88.00000 | KG | 20160704 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124216343 | 12421634 | 1 | PS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 120 MG, QD | U | 40664 | 120 | MG | POWDER FOR INJECTION | QD | |||||
| 124216343 | 12421634 | 2 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | UNK | U | 40664 | POWDER FOR INJECTION | |||||||||
| 124216343 | 12421634 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 60 MG, QD | U | 0 | 60 | MG | QD | ||||||
| 124216343 | 12421634 | 4 | SS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | U | 62911 | |||||||||||
| 124216343 | 12421634 | 5 | SS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | U | 19999 | |||||||||||
| 124216343 | 12421634 | 6 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1000 MG 2 IN 1 D | 0 | 1000 | MG | BID | |||||||
| 124216343 | 12421634 | 7 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 124216343 | 12421634 | 8 | SS | GANCICLOVIR. | GANCICLOVIR | 1 | U | 0 | |||||||||||
| 124216343 | 12421634 | 9 | SS | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 124216343 | 12421634 | 10 | SS | INCB039110 | INVESTIGATIONAL PRODUCT | 1 | Oral | 200 MG, 1X/DAY IN 1 D | N | 0 | 200 | MG | TABLET | QD | |||||
| 124216343 | 12421634 | 11 | C | CYCLOSPORINE. | CYCLOSPORINE | 1 | Intravenous (not otherwise specified) | 50-100 MG, 1 IN 1 D | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124216343 | 12421634 | 1 | Graft versus host disease |
| 124216343 | 12421634 | 3 | Graft versus host disease |
| 124216343 | 12421634 | 6 | Infection prophylaxis |
| 124216343 | 12421634 | 7 | Prophylaxis against graft versus host disease |
| 124216343 | 12421634 | 10 | Graft versus host disease |
| 124216343 | 12421634 | 11 | Infection prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124216343 | 12421634 | DE |
| 124216343 | 12421634 | HO |
| 124216343 | 12421634 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124216343 | 12421634 | Acute kidney injury | |
| 124216343 | 12421634 | Hypotension | |
| 124216343 | 12421634 | Infection | |
| 124216343 | 12421634 | Melaena | |
| 124216343 | 12421634 | Multiple organ dysfunction syndrome | |
| 124216343 | 12421634 | Pancytopenia | |
| 124216343 | 12421634 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124216343 | 12421634 | 1 | 20160426 | 20160509 | 0 | |
| 124216343 | 12421634 | 2 | 20160510 | 0 | ||
| 124216343 | 12421634 | 3 | 20160422 | 20160426 | 0 | |
| 124216343 | 12421634 | 6 | 20160425 | 0 | ||
| 124216343 | 12421634 | 10 | 20160505 | 20160509 | 0 | |
| 124216343 | 12421634 | 11 | 20160425 | 20160509 | 0 |